Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

UnitedHealth flashes major bullish signal after catastrophic crash

UnitedHealth flashes major bullish signal after catastrophic crash
Paul L.
Stocks

UnitedHealth Group (NYSE: UNH) stock has flashed a major bullish technical signal, forming its first golden cross since July 2024.

Indeed, this formation comes as a relief, considering UNH stock remains deeply scarred by a brutal earnings-driven collapse.

The signal emerged in late January 2026, when the 50-day moving average (MA) crossed above the 200-day moving average, signaling improving short-term momentum after months of heavy selling. 

Notably, the gold cross follows a near-historic drawdown, with UnitedHealth trading around $287, down from 2024 highs above $550, representing a peak-to-trough decline of roughly 48%. 

UNH stock price analysis chart. Source: Barchart

While losses mounted through 2025, the sharpest leg lower came in January 2026 after the company’s Q4 2025 earnings and weaker 2026 outlook. To this end, UNH plunged by about 20% in a single day trading. 

For most of 2025, the 50-day moving average stayed below the 200-day line, signaling sustained bearish control, but the recent crossover indicates easing downside momentum and the potential start of base-building, even as price remains well below prior highs. 

UNH stock crash 

UnitedHealth has tapered lower since the recent breakdown, and the $330–$350 zone, where the earnings-driven selloff began, remains a key resistance that must be reclaimed to signal a durable trend reversal.

It’s worth noting that UnitedHealth posted Q4 2025 revenue of $113.2 billion, missing expectations of about $113.7 billion by roughly $530 million. 

Although adjusted EPS of $2.11 met forecasts, investors focused on the underlying weakness rather than the headline result. 

The bigger blow came from 2026 guidance, with the company projecting revenue above $439 billion, well below consensus near $454 billion. 

This implies a rare year-over-year decline from 2025 revenue of about $447.6 billion, breaking the market’s long-held growth assumptions.

At the same time, the earnings disappointment also collided with a critical technical level. At the start of 2026, UnitedHealth shares rallied into the $330–$340 range, testing the 200-day moving average near $329.

Featured image via Shutterstock

Best Crypto Exchange for Intermediate Traders and Investors

  • Invest in cryptocurrencies and 3,000+ other assets including stocks and precious metals.

  • 0% commission on stocks - buy in bulk or just a fraction from as little as $10. Other fees apply. For more information, visit etoro.com/trading/fees.

  • Copy top-performing traders in real time, automatically.

  • eToro USA is registered with FINRA for securities trading.

30+ million Users worldwide
Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Finbold.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD
Finbold Career

Join Finbold's newsroom, become a crypto reporter today!

Apply now to join Finbold as a crypto/finance news writer!

Latest posts

Finance Digest

By subscribing you agree with Finbold T&C’s & Privacy Policy

Related posts

Stocks

Finbold AI Agent

How AI Price Predictions Work

We use cutting-edge AI models to forecast future prices for stocks and crypto.

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.